Team:Yale/Results
From 2014.igem.org
(8 intermediate revisions not shown) | |||
Line 135: | Line 135: | ||
<li><strong>T7 RNA polymerase design and creation</strong> | <li><strong>T7 RNA polymerase design and creation</strong> | ||
<p> | <p> | ||
- | The T7 Riboregulation System works by a “three-lock system.” The first lock is the cis- repressing RNA (crRNA), which is induced bysopropyl β-D-1-thiogalactopyranoside (IPTG). The second lock is the trans-activating RNA (taRNA), which is induced by anhydrous tetracycline (ATC). If the taRNA is unlocked, it will bind to the crRNA, removing the hairpin and making the ribosomal binding site accessible for ribosomal binding, leading to translation of a specific protein, in this case, T7 RNA Polymerase. This system was initially developed by Dr. Farren Isaacs, and has been shown to work with chloramphenicol resistance (chloramphenical acetyl transferase gene) in place of the T7 gene. The plasmid was synthesized via Gibson assembly, and confirmed by sequencing. | + | The T7 Riboregulation System works by a “three-lock system.” The first lock is the cis-repressing RNA (crRNA), which is induced bysopropyl β-D-1-thiogalactopyranoside (IPTG). The second lock is the trans-activating RNA (taRNA), which is induced by anhydrous tetracycline (ATC). If the taRNA is unlocked, it will bind to the crRNA, removing the hairpin and making the ribosomal binding site accessible for ribosomal binding, leading to translation of a specific protein, in this case, T7 RNA Polymerase. This system was initially developed by Dr. Farren Isaacs, and has been shown to work with chloramphenicol resistance (chloramphenical acetyl transferase gene) in place of the T7 gene. The plasmid was synthesized via Gibson assembly, and confirmed by sequencing. |
<br> | <br> | ||
<br> | <br> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/6/66/Yale_figure7.png"></center> | + | <center><img style='border:2px solid #000000' src="https://static.igem.org/mediawiki/2014/6/66/Yale_figure7.png"></center> |
<p> | <p> | ||
<center> | <center> | ||
<i><strong>Figure 1.</strong> Preliminary gel screening of Mach 1 strains containing transformed pZE21_A12C_T7RNA plasmids created via Gibson Assembly. Used combinations of general pZE21 sequencing primers, F: CAGGGCTTCCCAACCTTAC, R: CGCCTTTGAGTGAGCTGATA, and internal T7 primers, F: TCCCTTACAACATGGACTGGC, R: CCCACCAAGTGTTCTCCAG. The corresponding sizes are labelled on the side. The negative control for the external primers is the ancestor plasmid, which contains chloramphenicol acetyl transferase (CAT) instead of T7, and is 1.1 kb instead of 3.3 kb.</i></center><br></p> | <i><strong>Figure 1.</strong> Preliminary gel screening of Mach 1 strains containing transformed pZE21_A12C_T7RNA plasmids created via Gibson Assembly. Used combinations of general pZE21 sequencing primers, F: CAGGGCTTCCCAACCTTAC, R: CGCCTTTGAGTGAGCTGATA, and internal T7 primers, F: TCCCTTACAACATGGACTGGC, R: CCCACCAAGTGTTCTCCAG. The corresponding sizes are labelled on the side. The negative control for the external primers is the ancestor plasmid, which contains chloramphenicol acetyl transferase (CAT) instead of T7, and is 1.1 kb instead of 3.3 kb.</i></center><br></p> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/f/f2/Yale_sequences_1.png"></center> | + | <center><img style='border:2px solid #000000' src="https://static.igem.org/mediawiki/2014/f/f2/Yale_sequences_1.png"></center> |
<p> | <p> | ||
Line 157: | Line 157: | ||
Experimental plan for the GFP fluorescence assay testing the efficacy of the T7 riboregulation system. The T7 riboregulation system, pZE21_A12C_T7RNA, would express sfGFP behind a T7 promoter, in the plasmid pZA21. Either plasmid, and both plasmids together, were transformed into ECNR2 and induced with either IPTG and ATC. ECNR2 is the ancestral strain. A positive control was the same pZA21_T7sfGFP plasmid in ECNR2, and the same T7 RNA polymerase gene inserted in a regular pZE21 plasmid with a pLtetO promoter, and a negative control with the pZA21_T7sfGFP in ECNR2 without any plasmid that contains T7 RNA. </p> <br> | Experimental plan for the GFP fluorescence assay testing the efficacy of the T7 riboregulation system. The T7 riboregulation system, pZE21_A12C_T7RNA, would express sfGFP behind a T7 promoter, in the plasmid pZA21. Either plasmid, and both plasmids together, were transformed into ECNR2 and induced with either IPTG and ATC. ECNR2 is the ancestral strain. A positive control was the same pZA21_T7sfGFP plasmid in ECNR2, and the same T7 RNA polymerase gene inserted in a regular pZE21 plasmid with a pLtetO promoter, and a negative control with the pZA21_T7sfGFP in ECNR2 without any plasmid that contains T7 RNA. </p> <br> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/f/ff/Yale_figure8.png"></center> | + | <center><img style='border:2px solid #000000' src="https://static.igem.org/mediawiki/2014/f/ff/Yale_figure8.png"></center> |
<p> | <p> | ||
Line 163: | Line 163: | ||
<i><strong>Figure 3.</strong> The functionalities behind the GFP assay as described above.</i></center><br></p> | <i><strong>Figure 3.</strong> The functionalities behind the GFP assay as described above.</i></center><br></p> | ||
- | <center><img src="https://static.igem.org/mediawiki/2014/0/03/Yale_figure9.png"></center> | + | <center><img style='border:2px solid #000000' src="https://static.igem.org/mediawiki/2014/0/03/Yale_figure9.png"></center> |
<p> | <p> | ||
Line 218: | Line 218: | ||
<li><strong> Functional Assay</strong><p> | <li><strong> Functional Assay</strong><p> | ||
- | + | Functional assays are ongoing and results will be presented at the jamboree.</p> | |
<tr> | <tr> | ||
Line 229: | Line 229: | ||
<ol type="I"> | <ol type="I"> | ||
<li><strong>Mass Retention of Mussel Adhesion Proteins (MAPs) Under Stress</strong> | <li><strong>Mass Retention of Mussel Adhesion Proteins (MAPs) Under Stress</strong> | ||
- | <p>Preliminary proof of concept testing was conducted on a commercially available MAP-based product known as Cell-Tak <sup>TM</sup>. Cell-Tak<sup>TM</sup> is designed to facilitate cell adhesion to normally non-biocompatible surfaces such as microscope slides and petri dishes. We deposited ~20 µg films of Cell-Tak onto borosilicate substrates and proceeded to erode them under deionized H<sub>2</sub>O and 5% acetic acid. The results from this experiment are presented below and illustrate the design of our assay to test a variety of solvent and erosion conditions on MAP films. A | + | <p>Preliminary proof of concept testing was conducted on a commercially available MAP-based product known as Cell-Tak <sup>TM</sup>. Cell-Tak<sup>TM</sup> is designed to facilitate cell adhesion to normally non-biocompatible surfaces such as microscope slides and petri dishes. We deposited ~20 µg films of Cell-Tak onto borosilicate substrates and proceeded to erode them under deionized H<sub>2</sub>O and 5% acetic acid. The results from this experiment are presented below and illustrate the design of our assay to test a variety of solvent and erosion conditions on MAP films. A microbalance (Mettler Toledo MX5) that can read to uncertainties of 1 µg was used to determine the mass of protein remaining after subjecting the substrate to erosion. An exponential decay curve was fitted to these experiments giving decay rates of 0.002 µg/pass and 0.046 µg/pass for deionized H<sub>2</sub>O and 5% acetic acid, respectively. As lower pH reverses the coordination of L-DOPA, it is expected that the acidic conditions engender the higher rate of decay. This experiment presents a preliminary result that validates our ability to apply erosion onto MAP-coated surfaces. We intend to apply a similar protocol to metal and plastic surfaces as well as erode surfaces under different pH conditions to provide a more comprehensive picture of the optimal conditions for mussel adhesion. |
<center><img src="https://static.igem.org/mediawiki/2014/a/aa/Erosion_Fig_iGEMwiki.png" height = 300 width = auto></center> | <center><img src="https://static.igem.org/mediawiki/2014/a/aa/Erosion_Fig_iGEMwiki.png" height = 300 width = auto></center> | ||
<p> | <p> | ||
Line 239: | Line 239: | ||
<p> | <p> | ||
<center> | <center> | ||
- | <i><strong>Figure 6.</strong><strong>(A)</strong> The profile photograph of a drop on an untreated silica substrate used for contact angle determination. <strong>(B)</strong> The profile photograph of a Cell-Tak <sup>TM</sup> treated surface used for contact angle determination.</i></center></p> | + | <i><strong>Figure 6.</strong><strong> (A)</strong> The profile photograph of a drop on an untreated silica substrate used for contact angle determination. <strong>(B)</strong> The profile photograph of a Cell-Tak <sup>TM</sup> treated surface used for contact angle determination.</i></center></p> |
Latest revision as of 03:53, 18 October 2014
Results |
|||||||||||||||||||||||||||||||||||||||||
T7 Riboregulation System
| |||||||||||||||||||||||||||||||||||||||||
Ampersand Construct
|